Trinucleotide Repeat Expansion clinical trials at UC Davis

1 research study open to eligible people

Showing trials for

  • Metformin in Individuals With Fragile X Syndrome

    “Learn if Metformin may be helpful for language, behavior problems, and obesity / excessive appetite in patients with Fragile X Syndrome.”

    open to eligible people ages 6-25

    This study is a controlled trial of metformin in individuals with fragile X syndrome between the ages of 6 and 25 years. Participants will be randomized in a double-blind design to either drug or placebo and will attend three visits to the study site in a 4-month period for a series of tests. The primary objectives are to assess safety, tolerability, and efficacy of metformin in the treatment of language deficits, behavior problems, and obesity/excessive appetite in individuals with fragile X syndrome.

    Sacramento, California and other locations

Our lead scientists for Trinucleotide Repeat Expansion research studies include .

Last updated: